Does Medical Cannabis Reduce the Severity of Panic Disorder?

PostedMarch 2, 2026

UpdatedMarch 2, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Research is exploring the impact of cannabis on severity of panic disorder as a potential complementary treatment. Cannabinoids like CBD may provide calming effects that contribute to symptom reduction and help patients better manage acute episodes.

Understanding the medical marijuana effects alongside traditional therapies may improve overall treatment outcomes. Early studies suggest that careful integration of cannabis under professional guidance can support emotional regulation and reduce the intensity of panic episodes.

How Medical Cannabis May Help

Patients considering cannabis should do so with professional supervision to ensure safety and effectiveness. Awareness of how the impact of cannabis on severity of panic disorder interacts with other therapies is key to optimising results.

Reduced Panic Intensity

Cannabinoids may lower the severity and frequency of panic episodes, helping patients regain control and confidence.

Anxiety Management

Medical cannabis can provide relaxation and support emotional stability, contributing to better symptom reduction.

Enhanced Treatment Outcomes

When combined with therapy, medical marijuana effects may improve long-term treatment outcomes and overall quality of life.

In conclusion, the impact of cannabis on severity of panic disorder shows promise for supportive care. Professional guidance is essential for safe use.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder .

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.